Podcast Episodes

Back to Search
Navigating PBM Pitfalls: Protecting Revenue in a Complex Rebate Landscape
Navigating PBM Pitfalls: Protecting Revenue in a Complex Rebate Landscape

In this episode of Pricing & Policy with Model N, Jesse Mendelsohn, senior vice president at Model N, joins host Mike Christel to offer a candid, ex…

5 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: New FDA Draft Guidance Targets Gene Therapy Submission Burden
Pharmaceutical Executive Daily: New FDA Draft Guidance Targets Gene Therapy Submission Burden

In today's Pharmaceutical Executive Daily, Cam Olig of Prescryptive Health touches on the results of a new market access survey, Eli Lilly and Ascidi…

5 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301
Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301

In today's Pharmaceutical Executive Daily, FDA has accepted a new drug application for giredestrant under priority review, FDA also issues a complete…

5 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Xocova
Pharmaceutical Executive Daily: FDA Approves Xocova

In today's Pharmaceutical Executive Daily, the FDA approves Shionogi's Xocova, a pharma M&A roundup covers Servier's acquisition of Edgewise Therapeu…

5 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: WHO Identifies Priority Treatment Candidates for Ebola
Pharmaceutical Executive Daily: WHO Identifies Priority Treatment Candidates for Ebola

In today’s Pharmaceutical Executive Daily, Harpreet Singh discusses the evolving regulatory landscape for biopharma, the World Health Organization id…

5 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo
Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo

In today’s Pharmaceutical Executive Daily, an FDA advisory committee weighs recommendations for the composition of the 2026–2027 Covid-19 vaccines, C…

5 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Hepcludex
Pharmaceutical Executive Daily: FDA Approves Hepcludex

In today’s Pharmaceutical Executive Daily, Eli Lilly announces three acquisitions totaling roughly $3 billion, the FDA approves Hepcludex as the firs…

5 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Datroway
Pharmaceutical Executive Daily: FDA Approves Datroway

5 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: What It Takes to Move Machine Learning
Pharmaceutical Executive Daily: What It Takes to Move Machine Learning

In today's Pharmaceutical Executive Daily, Reuters reports that lower-priced oral GLP-1 pills from Eli Lilly and Novo Nordisk are drawing patients aw…

5 months, 4 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio

In today's Pharmaceutical Executive Daily, Eli Lilly announces a deal worth up to $202 million for Engage Biologics and its preclinical non-viral DN…

5 months, 4 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us